• Olexandr Sklyarov Danylo Halytsky Lviv National Medical University Lviv, Ukraine
Keywords: histamine, gastrin, acethylcholine, ECL-cells, parietal cells, receptors to histamine, neuroendocrine stomach neoplasms


Despite the fact that investigations of histamine started in the beginning of the last century by Leon Popelski, within next hundred years and till now this biogenic amine is in the field of interests of many researchers. The studies of the turnover of histamine, its mechanism of effect on the secretory cells of the stomach, determination of types and localization of the receptors on membranes of different cells, envolvement in pathochemical processes and application of selective receptors blockers enabled to state the significant role of histamine in the organism. Inhibitors of proton pump (IPP) cause hypergastrinemia, hyperplasia of enterochromaffin endocrine cells and risk of developing neuroendocrine tumor in patients with gastritis, caused by H. pylori and cancer development in patients who have susceptibility to Barrett’s oesophagus. Against a background of chronical IPP use in patients with pernicious anemia and chronic gastritis is also marked an increased risk of gastric neuroendocrine tumors. Regulation of interrelationship between key stimulators and inibitors of stomach secretion (acethylcholine, gastrin, histamine, somatostatin, prostaglandins) and their role in the processes of cytoprotection, cancerogenesis are one of the key questions of today.


Download data is not yet available.


Alonso N, Zappia CD, Cabrera M, Davio CA, Shayo C, Monczor F, Fernández NC. Physiological implications of biased signaling at histamine H2 receptors. Frontiers in pharmacology. 2015 Mar 10;6:45.


Aurelius J, Martner A, Brune M, Palmqvist L, Hansson M, Hellstrand K, Thorén FB. Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells. Haematologica. 2012 Dec 1;97(12):1904-8. https://doi.org/10.3324/haematol.2012.066399

Chen D, Aihara T, Zhao CM, Håkanson R, Okabe S. Differentiation of the Gastric Mucosa I. Role of histamine in control of function and integrity of oxyntic mucosa: understanding gastric physiology through disruption of targeted genes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2006 Oct;291(4):G539-44.

Dale HH, Laidlaw PP. The physiological action of β‐ The Journal of Physiology. 1910 Dec 31;41(5):318-44. https://doi.org/10.1113/jphysiol.1910.sp001406

Hershcovici T, Fass R. Gastro-Oesophageal Reflux Disease. Drugs. 2011 Dec 1;71(18):2381-9. https://doi.org/10.2165/11597300-000000000-00000

Ko Y, Tang J, Sanagapalli S, Kim BS, Leong RW. Safety of proton pump inhibitors and risk of gastric cancers: review of literature and pathophysiological mechanisms. Expert opinion on drug safety. 2016 Jan 2;15(1):53-63. https://doi.org/10.1517/14740338.2016.1118050

La Rosa S, Vanoli A. Gastric neuroendocrine neoplasms and related precursor lesions. Journal of clinical pathology. 2014 Jul 22:jclinpath-2014;67(11):2381-9.

Lundell L, Vieth M, Gibson F, Nagy P, Kahrilas PJ. Systematic review: the effects of long‐term proton pump inhibitor use on serum gastrin levels and gastric histology. Alimentary pharmacology & therapeutics. 2015 Sep 1;42(6):649-63. https://doi.org/10.1111/apt.13324

Luo T, Chen B, Zhao Z, He N, Zeng Z, Wu B, Fukushima Y, Dai M, Huang Q, Xu D, Bin J. Histamine H2 receptor activation exacerbates myocardial ischemia/reperfusion injury by disturbing mitochondrial and endothelial function. Basic research in cardiology. 2013 May 1;108(3):342. https://doi.org/10.1007/s00395-013-0342-4

Monczor F, Fernandez N. Current knowledge and perspectives on histamine H1 and H2 receptor pharmacology: functional selectivity, receptor crosstalk, and repositioning of classic histaminergic ligands. Molecular pharmacology. 2016 Nov 1;90(5):640-8. https://doi.org/10.1124/mol.116.105981

Nieto-Alamilla G, Márquez-Gómez R, García-Gálvez AM, Morales-Figueroa GE, Arias-Monta-o JA. The histamine H3 receptor: structure, pharmacology, and function. Molecular pharmacology. 2016 Nov 1;90(5):649-73. https://doi.org/10.1124/mol.116.104752

Notcovich C, Diez F, Tubio MR, Baldi A, Kazanietz MG, Davio C, Shayo C. Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways. Experimental cell research. 2010 Feb 1;316(3):401-11. https://doi.org/10.1016/j.yexcr.2009.11.002

Panasyuk EN, Sklyarov YaP, Karpenko LN. Ultrastrukturnuye i mikrochimicheskiye prozessu v geludochnuch gelezach. Kiev. Zdorov’ya. 1979:136.

Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL. International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacological reviews. 2015 Jul 1;67(3):601-55. https://doi.org/10.1124/pr.114.010249

Popielski L. O fizjologicznych własnościach ß-imidazolyletylaminy. Rozpr. Wydziału Mat. Przyr. 1916; III AU s. 3(16)B:449-474.

Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short‐term treatment with proton pump inhibitors, H2‐receptor antagonists and prokinetics for gastro‐oesophageal reflux disease‐like symptoms and endoscopy negative reflux disease. The Cochrane Library. 2013 Jan 1;5:CDOO2095.

Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008 Jun 1;134(7):1842-60. https://doi.org/10.1053/j.gastro.2008.05.021

Sklyarov O. Histamin u shlunku: mynule, s”ohodennya i majbutnye. Praci naukovoho tovarystva im. Shevchenka. Medychni nauky. 2016(47):28-33.

Sklyarov AY, Panasyuk EN, Timochko MF. Vzaimootnochenie megdu okislitelnovostanovitelnumi reakziyami i napryageniem kisloroda v slizistoy obolochke geludka krus pri deystviyi mediatornuch vechestv. Fiziologicheskiy gurnal SSSR im. I.M.Sechenova. 1991;77 (10):86 – 93.

Sklyarov O. Histamin u shlunku: mynule, s”ohodennya i majbutnye. Praci naukovoho tovarystva im. Shevchenka. Medychni nauky. 2016(47):28-33.

Sklyarov AY, Kosuyi ER., Sklyarov EY. Osnovu gastroenterologii. Lviv – Kvart. 2011:289.

Sklyarov YaP. Geludochnaya sekreziya. Kiev-Gosudarstvennoe medizinskoe izdatelstvo USSR.1954:190.

Sklyarov YaP. Geludochnaya sekreziya. (Vtoroe izdaniye). Moskva-Medgiz.1961:219.

Zampeli E, Tiligada E. The role of histamine H4 receptor in immune and inflammatory disorders. British journal of pharmacology. 2009 May 1;157(1):24-33. https://doi.org/10.1111/j.1476-5381.2009.00151.x

Zeng Z, Shen L, Li X, Luo T, Wei X, Zhang J, Cao S, Huang X, Fukushima Y, Bin J, Kitakaze M. Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis. Clinical science. 2014 Oct 1;127(7):435-48. https://doi.org/10.1042/CS20130716

M Zhao C, Chen D. The ECL cell: relay station for gastric integrity. Current medicinal chemistry. 2012 Jan 1;19(1):98-108. https://doi.org/10.2174/092986712803414060

Abstract views: 43
PDF Downloads: 312 PDF Downloads: 0
How to Cite
Sklyarov O. HISTAMINE IN THE STOMACH: PAST, PRESENT AND FUTURE. Proc Shevchenko Sci Soc Med Sci [Internet]. 2016Nov.16 [cited 2021Feb.26];47(2):28-0. Available from: https://mspsss.org.ua/index.php/journal/article/view/23